Sort by
Refine Your Search
-
stem cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an
-
validation of these models using human induced pluripotent stem cells (hiPSCs). In collaboration with members of the OMBION consortium, you will further expand our systems to include relevant pain-associated
-
cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an affinity
-
contribute directly to this effort by developing patient-specific induced pluripotent stem cell (iPSC)-derived vascular tissues to assess disease severity, drug efficacy and the potential of gene-correction
-
modelling approaches (https://www.carlier-insilico-lab.com/who-are-we) . Dr LaPointe’s group (www.lapointelab.com ) is dedicated to developing groundbreaking regenerative cell therapies that can transform the
-
or stem cell models is a plus. For more information, please contact Joana Silva (j.r.fariadasilva@umcutrecht.nl ). If you would like to apply, please send your CV, a motivation letter, and the contact
-
engineering, molecular biology, or a related field; You have solid hands-on experience with in-vitro techniques such as neuronal or stem-cell culture, immunocytochemistry,microscopy, or electrophysiology; You
-
of Genome Function and Cell Identity, relevant for stem cell biology and cancer. In total, there are 14 beneficiaries and 12 partner organisations. Where to apply Website https://www.academictransfer.com/en